The impact of the COVID-19 on the antifungal consumption and antifungal resistance in Candida species isolated from the blood cultures of critically ill patients in intensive care units
Medical Mycology · 2025
DOI: 10.1093/mmy/myaf002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Mycology, 2025. Verfasst von Emre Kara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hacettepe University Faculty of Pharmacy, Department of Clinical Pharmacy, Ankara, Turkiye. Hauptthemen laut MEDLINE: Antifungal Agents, COVID-19, Drug Resistance, Fungal, Candida. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Themen: Intensivpflege
Abstract (Originalsprache)
Incidence of Candida species increased in critically ill COVID-19 patients in intensive care units. This study aimed to investigate the impact of the COVID-19 pandemic on antifungal consumption and Candida species distribution in bloodstream infections. We observed that a significant increase in non-albicansCandida species cases (P = .005) in 2021 coincided with higher rates of fluconazole resistance (P = .002) and increased minimum inhibitory concentrations for echinocandins (P = .012). Notably, voriconazole consumption and increased MIC levels positively correlated with both Candida albicans and non-albicansCandida species. This study underscores the importance of judicious antifungal use during the COVID-19 pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hacettepe University Faculty of Pharmacy, Department of Clinical Pharmacy, Ankara, Turkiye.
- Hacettepe University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Ankara, Turkiye.
- Hacettepe University Faculty of Medicine, Department of Medical Microbiology, Ankara, Turkiye.
Zitieren
APA
Kara, E., Metan, G., Gülmez, D., & Arikan-Akdagli, S. (2025). The impact of the COVID-19 on the antifungal consumption and antifungal resistance in Candida species isolated from the blood cultures of critically ill patients in intensive care units. Medical Mycology. https://doi.org/10.1093/mmy/myaf002
Vancouver
Kara E, Metan G, Gülmez D, Arikan-Akdagli S. The impact of the COVID-19 on the antifungal consumption and antifungal resistance in Candida species isolated from the blood cultures of critically ill patients in intensive care units. Medical Mycology. 2025. doi:10.1093/mmy/myaf002
BibTeX
@article{Kara2025,
author = {Kara, Emre and Metan, Gokhan and Gülmez, Dolunay and Arikan-Akdagli, Sevtap},
title = {The impact of the COVID-19 on the antifungal consumption and antifungal resistance in Candida species isolated from the blood cultures of critically ill patients in intensive care units},
journal = {Medical Mycology},
year = {2025},
doi = {10.1093/mmy/myaf002}
}
EUVIMED